Kevin J Appelbaum - Net Worth and Insider Trading
Kevin J Appelbaum Net Worth
The estimated net worth of Kevin J Appelbaum is at least $241 dollars as of 2024-12-25. Kevin J Appelbaum is the CEO, 10% Owner of Better Therapeutics Inc and owns about 2,410,469 shares of Better Therapeutics Inc (BTTX) stock worth over $241. Details can be seen in Kevin J Appelbaum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin J Appelbaum has not made any transactions after 2021-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin J Appelbaum
Kevin J Appelbaum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin J Appelbaum owns 2 companies in total, including Better Therapeutics Inc (BTTX) , and Mountain Crest Acquisition Corp II (MCADU) .
Click here to see the complete history of Kevin J Appelbaum’s form 4 insider trades.
Insider Ownership Summary of Kevin J Appelbaum
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BTTX | Better Therapeutics Inc | 2021-12-20 | director & 10 percent owner & Chief Executive Officer |
MCADU | Mountain Crest Acquisition Corp II | 2021-10-28 | director & 10 percent owner & Chief Executive Officer |
Kevin J Appelbaum Latest Holdings Summary
Kevin J Appelbaum currently owns a total of 1 stock. Kevin J Appelbaum owns 2,410,469 shares of Better Therapeutics Inc (BTTX) as of December 20, 2021, with a value of $241.
Latest Holdings of Kevin J Appelbaum
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BTTX | Better Therapeutics Inc | 2021-12-20 | 2,410,469 | 0.00 | 241 |
Holding Weightings of Kevin J Appelbaum
Kevin J Appelbaum Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin J Appelbaum has made a total of 4 transactions in Better Therapeutics Inc (BTTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Better Therapeutics Inc is the acquisition of 1,000 shares on December 20, 2021, which cost Kevin J Appelbaum around $4,600.
Insider Trading History of Kevin J Appelbaum
- 1
Kevin J Appelbaum Trading Performance
GuruFocus tracks the stock performance after each of Kevin J Appelbaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin J Appelbaum is -47.93%. GuruFocus also compares Kevin J Appelbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin J Appelbaum within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin J Appelbaum's insider trading performs compared to the benchmark.
Performance of Kevin J Appelbaum
Kevin J Appelbaum Ownership Network
Kevin J Appelbaum Owned Company Details
What does Better Therapeutics Inc do?
Who are the key executives at Better Therapeutics Inc?
Kevin J Appelbaum is the director & 10 percent owner & Chief Executive Officer of Better Therapeutics Inc. Other key executives at Better Therapeutics Inc include director & See Remarks Frank Karbe , director & 10 percent owner & See Remarks David P Perry , and Chief Medical Officer Mark A. Berman .
Better Therapeutics Inc (BTTX) Insider Trades Summary
Over the past 18 months, Kevin J Appelbaum made no insider transaction in Better Therapeutics Inc (BTTX). Other recent insider transactions involving Better Therapeutics Inc (BTTX) include a net purchase of 1,233,045 shares made by David P Perry , a net purchase of 685,025 shares made by Geoffrey M. Parker , and a net purchase of 274,010 shares made by Andrew J. Armanino .
In summary, during the past 3 months, insiders sold 0 shares of Better Therapeutics Inc (BTTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Better Therapeutics Inc (BTTX) were sold and 2,418,138 shares were bought by its insiders, resulting in a net purchase of 2,418,138 shares.
Better Therapeutics Inc (BTTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Better Therapeutics Inc Insider Transactions
Kevin J Appelbaum Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin J Appelbaum. You might contact Kevin J Appelbaum via mailing address: 4160 Dublin Blvd., Suite 200, Dublin Ca 94568.